PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity

Journal of Nutrition

Volumn 145, Issue 8, 2015, Pages 1687-1691

  Mondul, Alison ^a   Mancina, Rosellina M ^b   Merlo, Andrea ^c,d   Dongiovanni, Paola ^c,d   Rametta, Raffaela ^c,d   Montalcini, Tiziana ^e   Valenti, Luca ^c,d   Albanes, Demetrius ^a   Romeo, Stefano ^b,e,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

NAFLD; Obesity; PNPLA3; RBP4; Retinol

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; ENZYME; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3; RETINOL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN;

ADULT; ALLELE; ARTICLE; CANCER PREVENTION; ENZYME ACTIVITY; EX VIVO STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; SMOKING; STELLATE CELL; AGED; BLOOD; GENETICS; METABOLISM;

AGED; FEMALE; GENETIC VARIATION; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OVERWEIGHT; VITAMIN A;

EID: 84938918316     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.210633     Document Type: Article

References (27)

1. Goodman DW, Huang HS, Shiratori T. Tissue distribution and metabolism of newly absorbed vitamin A in the rat. J Lipid Res 1965;6:390-6.
2. Blomhoff R, Rasmussen M, Nilsson A, Norum KR, Berg T, Blaner WS, Kato M, Mertz JR, Goodman DS, Eriksson U, et al. Hepatic retinol metabolism: distribution of retinoids, enzymes, and binding proteins in isolated rat liver cells. J Biol Chem 1985;260:13560-5.
3. Blaner WS, O'Byrne SM, Wongsiriroj N, Kluwe J, D'Ambrosio DM, Jiang H, Schwabe RF, Hillman EM, Piantedosi R, Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta 2009;1791:467-73.
4. Blomhoff R, Green MH, Berg T, Norum KR. Transport and storage of vitamin A. Science 1990;250:399-404.
5. Pirazzi C, Valenti L, Motta BM, Pingitore P, Hedfalk K, Mancina RM, Burza MA, Indiveri C, Ferro Y, Montalcini T, et al. PNPLA3 has retinylpalmitate lipase activity in human hepatic stellate cells. Hum Mol Genet 2014;23:4077-85.
6. Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989;10:308-16.
7. Smith FR, Goodman DS, Zaklama MS, Gabr MK, El-Maraghy S, Patwardhan VN. Serum vitamin A, retinol-binding protein, and prealbumin concentrations in protein-calorie malnutrition. I. A functional defect in hepatic retinol release. Am J Clin Nutr 1973;26:973-81.
8. Smith FR, Goodman DS, Arroyave G, Viteri F. Serum vitamin A, retinol-binding protein, and prealbumin concentrations in proteincalorie malnutrition. II. Treatment including supplemental vitamin A. Am J Clin Nutr 1973;26:982-7.
9. Rosales FJ, Ritter SJ, Zolfaghari R, Smith JE, Ross AC. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. J Lipid Res 1996;37:962-71.
10. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
11. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1209-17.
12. Alicandro G, Faelli N, Gagliardini R, Santini B, Magazzù G, Biffi A, Risé P, Galli C, Tirelli AS, Loi S, et al. A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 2013;88:163-9.
13. ATBC Cancer Prevention Study Group. The alpha-tocopherol, betacarotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10.
14. Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene, and alphaand beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874-6.
15. Tanumihardjo SA. Assessing vitamin A status: past, present and future. J Nutr 2004;134(Suppl):290S-3S.
16. Pingitore P, Pirazzi C, Mancina RM, Motta BM, Indiveri C, Pujia A, Montalcini T, Hedfalk K, Romeo S. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. Biochim Biophys Acta 2013;1841: 574-80.
17. Huang Y, Cohen JC, Hobbs HH. Expression and characterization of a PNPLA3 isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem 2011;286:37085-93.
18. Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, Leonetti F, Capoccia D, Incani M, Maglio C, Iacovino M, et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 2010;34:190-4.
19. Romeo S, Cambuli VM, Incani M, Congiu T, Matta V, Pilia S, Huang-Doran I, Cossu E, Loche S, Baroni MG. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol 2010;53:335-8.
20. Santoro N, Savoye M, Kim G, Marotto K, Shaw MM, Pierpont B, Caprio S. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS ONE 2012;7:e37827.
21. Giudice EM, Grandone A, Cirillo G, Santoro N, Amato A, Brienza C, Savarese P, Marzuillo P, Perrone L. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS ONE 2011;6:e27933.
22. Palmer CN, Maglio C, Pirazzi C, Burza MA, Adiels M, Burch L, Donnelly LA, Colhoun H, Doney AS, Dillon JF, et al. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS ONE 2012;7:e39362.
23. Stojkovic IA, Ericson U, Rukh G, Riddestråle M, Romeo S, Orho-Melander M. The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels. Genes Nutr 2014;9:388.
24. Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol 2013;19:6969-78.
25. Valenti L, Dongiovanni P, Ginanni Corradini S, Burza MA, Romeo S. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease. Dig Liver Dis 2013;45:619-24.
26. Trépo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, Hamza S, Corradini SG, Burza MA, Guyot E, et al. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology 2014;59:2170-7.
27. Liu YL, Patman GL, Leathart JB, Piguet AC, Burt AD, Dufour JF, Day CP, Daly AK, Reeves HL, Anstee QM. Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of nonalcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol 2014;61:75-81.